{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T09:03:00Z","timestamp":1792918980715,"version":"4.5.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T00:00:00Z","timestamp":1780704000000},"content-version":"vor","delay-in-days":36,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100014180","name":"Government of Castile and Le\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014180","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","rpthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research and Practice in Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.rpth.2026.106792","type":"journal-article","created":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T01:11:22Z","timestamp":1781313082000},"page":"106792","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Efficacy and safety of recombinant activated factor VII for secondary prophylaxis in patients with Glanzmann thrombasthenia"],"prefix":"10.1016","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3814-0255","authenticated-orcid":false,"given":"Pablo","family":"Garc\u00eda-Ja\u00e9n","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuria","family":"Fern\u00e1ndez-Mosteirin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Luisa","family":"Serrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susana","family":"Riesco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Aguilar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Gabaldon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Kanaan-Leis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Almudena","family":"Gonz\u00e1lez-Prieto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"Portugal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Carmen","family":"Mendoza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Gilabert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Hortal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorena","family":"D\u00edaz-Ajenjo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Lama-Villanueva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alba Mei","family":"Gonz\u00e1lez-Gal\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"S\u00e1nchez-Fuentes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roc\u00edo","family":"Benito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Rivera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Ram\u00f3n","family":"Gonz\u00e1lez-Porras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8007-3909","authenticated-orcid":false,"given":"Jos\u00e9 Mar\u00eda","family":"Bastida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rpth.2026.106792_bib1","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1055\/s-0044-1782519","article-title":"Glanzmann thrombasthenia 10 years later: progress made and future directions","volume":"51","author":"Nurden","year":"2025","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.rpth.2026.106792_bib2","doi-asserted-by":"crossref","first-page":"888","DOI":"10.3324\/haematol.2018.214239","article-title":"Glanzmann thrombasthenia: genetic basis and clinical correlates","volume":"105","author":"Botero","year":"2020","journal-title":"Haematologica"},{"key":"10.1016\/j.rpth.2026.106792_bib3","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1055\/s-0033-1353393","article-title":"Glanzmann thrombasthenia: state of the art and future directions","volume":"39","author":"Nurden","year":"2013","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.rpth.2026.106792_bib4","doi-asserted-by":"crossref","first-page":"219","DOI":"10.2147\/JBM.S71319","article-title":"Glanzmann\u2019s thrombasthenia: pathogenesis, diagnosis, and current and emerging treatment options","volume":"6","author":"Solh","year":"2015","journal-title":"J Blood Med"},{"key":"10.1016\/j.rpth.2026.106792_bib5","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/bjh.15087","article-title":"Anti-\u03b1IIb \u03b23 immunization in Glanzmann thrombasthenia: review of literature and treatment recommendations","volume":"181","author":"Fiore","year":"2018","journal-title":"Br J Haematol"},{"key":"10.1016\/j.rpth.2026.106792_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpth.2024.102586","article-title":"Bleeding and quality of life in people with Glanzmann thrombasthenia: insights from the Glanzmann\u2019s 360 study","volume":"8","author":"Khair","year":"2024","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.rpth.2026.106792_bib7","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1111\/j.1538-7836.2004.00767.x","article-title":"Prophylactic and therapeutic recombinant factor VIIa administration in patients with Glanzmann\u2019s thrombasthenia: results of an international survey","volume":"2","author":"Poon","year":"2004","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.rpth.2026.106792_bib8","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1055\/s-0040-1718373","article-title":"The use of recombinant activated factor VII in patients with Glanzmann\u2019s thrombasthenia","volume":"121","author":"Poon","year":"2021","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.rpth.2026.106792_bib9","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/hae.15130","article-title":"Efficacy and safety of recombinant activated factor VII in Glanzmann thrombasthenia: a systematic literature review","volume":"31","author":"Saultier","year":"2025","journal-title":"Haemophilia"},{"key":"10.1016\/j.rpth.2026.106792_bib10","first-page":"1031","article-title":"The international, prospective Glanzmann Thrombasthenia Registry: treatment modalities and outcomes of non-surgical bleeding episodes","volume":"100","author":"Di Minno","year":"2015","journal-title":"Haematologica"},{"key":"10.1016\/j.rpth.2026.106792_bib11","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1111\/hae.70114","article-title":"European management of Glanzmann\u2019s thrombasthenia: a survey of current clinical practice","volume":"31","author":"Fiore","year":"2025","journal-title":"Haemophilia"},{"key":"10.1016\/j.rpth.2026.106792_bib13","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/MBC.0000000000001026","article-title":"Weekly low-dose recombinant factor VIIa prophylaxis in Glanzmann thrombasthenia","volume":"32","author":"Andi\u00e7","year":"2021","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.rpth.2026.106792_bib14","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/hae.14559","article-title":"Iron deficiency anemia and bleeding management in pediatric patients with Bernard-Soulier syndrome and Glanzmann thrombasthenia: a single-institution analysis","volume":"28","author":"Lee","year":"2022","journal-title":"Haemophilia"},{"key":"10.1016\/j.rpth.2026.106792_bib15","doi-asserted-by":"crossref","first-page":"e1120","DOI":"10.1097\/MPH.0000000000002105","article-title":"Use of rFVIIa in preventing recurrent intra-articular hemorrhages in a 15-year-old patient with Glanzmann thrombasthenia","volume":"43","author":"Laguna","year":"2021","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.rpth.2026.106792_bib16","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/MBC.0000000000001380","article-title":"Outcomes of recombinant activated factor VIIa (NovoSeven) therapy in Glanzmann thrombasthenia: two case reports","volume":"36","author":"Almatar","year":"2025","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.rpth.2026.106792_bib17","doi-asserted-by":"crossref","first-page":"148","DOI":"10.3324\/haematol.2017.171132","article-title":"Introducing high-throughput sequencing into mainstream genetic diagnosis practice in inherited platelet disorders","volume":"103","author":"Bastida","year":"2018","journal-title":"Haematologica"},{"key":"10.1016\/j.rpth.2026.106792_bib18","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1111\/jth.15263","article-title":"The ISTH bleeding assessment tool as predictor of bleeding events in inherited platelet disorders: communication from the ISTH SSC Subcommittee on Platelet Physiology","volume":"19","author":"Gresele","year":"2021","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.rpth.2026.106792_bib19","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1538-7836.2005.01204.x","article-title":"Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients","volume":"3","author":"Schulman","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.rpth.2026.106792_bib20","series-title":"Common Terminology Criteria for Adverse Events (CTCAE), version 5.0","year":"2017"},{"key":"10.1016\/j.rpth.2026.106792_bib21","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1111\/hae.14971","article-title":"Immune gene polymorphisms associated with poor response to platelet transfusion and recombinant factor VIIa administration in Glanzmann thrombasthenia","volume":"30","author":"Naderi","year":"2024","journal-title":"Haemophilia"},{"key":"10.1016\/j.rpth.2026.106792_bib22","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/hae.70030","article-title":"Obstetric and gynaecological challenges and outcomes in women and girls with Glanzmann\u2019s thrombasthenia","volume":"31","author":"Obeng-Tuudah","year":"2025","journal-title":"Haemophilia"},{"key":"10.1016\/j.rpth.2026.106792_bib23","doi-asserted-by":"crossref","first-page":"226","DOI":"10.25259\/IJMR_141_2025","article-title":"Natural history & quality of life in Glanzmann thrombasthenia & Bernard Soulier syndrome: an observational study from India","volume":"162","author":"Kharat","year":"2025","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.rpth.2026.106792_bib24","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/s44161-023-00418-4","article-title":"A bispecific antibody approach for the potential prophylactic treatment of inherited bleeding disorders","volume":"3","author":"Gandhi","year":"2024","journal-title":"Nat Cardiovasc Res"},{"issue":"Suppl 1","key":"10.1016\/j.rpth.2026.106792_bib25","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1182\/blood-2025-842","article-title":"Sutacimig, a novel bispecific antibody for prophylactic treatment of glanzmann thrombasthenia: analysis of a Phase 2 study","volume":"146","author":"Saultier","year":"2025","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2026.106792_bib26","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1016\/j.jtha.2024.05.033","article-title":"Targeting tissue factor pathway inhibitor with concizumab to improve hemostasis in patients with Glanzmann thrombasthenia: an in vitro study","volume":"22","author":"Dubut","year":"2024","journal-title":"J Thromb Haemost"}],"container-title":["Research and Practice in Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037926034503?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037926034503?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T11:24:09Z","timestamp":1784546649000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2475037926034503"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S2475037926034503"],"URL":"https:\/\/doi.org\/10.1016\/j.rpth.2026.106792","relation":{},"ISSN":["2475-0379"],"issn-type":[{"value":"2475-0379","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of recombinant activated factor VII for secondary prophylaxis in patients with Glanzmann thrombasthenia","name":"articletitle","label":"Article Title"},{"value":"Research and Practice in Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rpth.2026.106792","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}],"article-number":"106792"}}